Topical and systemic drug delivery to the posterior segments.

The posterior segments of the eye are exquisitely protected from the external environment. This poses unique and fairly challenging hurdles for drug delivery. It is somewhat dogmatic that topical ocular delivery is insufficient to achieve therapeutic drug levels in the posterior segments. However, some drugs are currently challenging this dogma. In this review we investigate the constraints and challenges of drug delivery to the posterior segment. Additionally, we outline several potential absorption pathways that may potentially be exploited to deliver drug to the back of the eye. Data on several compounds that achieve therapeutic posterior segment concentrations after topical dosing is presented. Finally, the issues surrounding systemic delivery to the posterior segment are reviewed.

[1]  T. F. Patton,et al.  Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. , 1987, Journal of pharmaceutical sciences.

[2]  L. Wheeler,et al.  alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.

[3]  K. Hosoya,et al.  Nucleoside transport mechanisms in the pigmented rabbit conjunctiva. , 1998, Investigative ophthalmology & visual science.

[4]  M. Mcdaniel,et al.  Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.

[5]  A. Mitra,et al.  Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine , 2003, Current eye research.

[6]  B. S. Winkler.  Retinal aerobic glycolysis revisited. , 1989, Investigative ophthalmology & visual science.

[7]  S. Nagamatsu,et al.  GLUT2 expression in the rat retina: localization at the apical ends of Müller cells , 1994, Brain Research.

[8]  A. Urtti,et al.  Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. , 2005, Investigative ophthalmology & visual science.

[9]  V. Ganapathy,et al.  Expression and Differential Polarization of the Reduced-folate Transporter-1 and the Folate Receptor α in Mammalian Retinal Pigment Epithelium* , 2000, The Journal of Biological Chemistry.

[10]  Y. Courtois,et al.  Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. , 1994, Biochemical and biophysical research communications.

[11]  D. Rethwisch,et al.  Penetration into the anterior chamber via the conjunctival/scleral pathway. , 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[12]  M. Wax,et al.  Expression of aquaporins in the rat ocular tissue. , 1997, Experimental eye research.

[13]  H. Tomita,et al.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye. , 2003, Investigative ophthalmology & visual science.

[14]  V. Ganapathy,et al.  Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse. , 2004, Biochimica et biophysica acta.

[15]  J. Pastor,et al.  Proliferative vitreoretinopathy: an overview. , 1998, Survey of ophthalmology.

[16]  Clive G. Wilson,et al.  Binding of Memantine to Melanin: Influence of Type of Melanin and Characteristics , 2003, Pharmaceutical Research.

[17]  L. Bito,et al.  The penetration of exogenous prostaglandin and arachidonic acid into, and their distribution within, the mammalian eye. , 1981, Current Eye Research.

[18]  N. Brecha,et al.  Expression of GAT‐1, a high‐affinity gamma‐aminobutyric acid plasma membrane transporter in the rat retina , 1994, The Journal of comparative neurology.

[19]  N. Philp,et al.  Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  A. Bozkurt,et al.  Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration , 1999, Eye.

[21]  D. Maurice,et al.  The active transport of fluorescein by the retinal vessels and the retina , 1967, The Journal of physiology.

[22]  M. Cour,et al.  Lactate transport mechanisms at apical and basolateral membranes of bovine retinal pigment epithelium. , 1994, The American journal of physiology.

[23]  H F Edelhauser,et al.  Transscleral drug delivery for posterior segment disease. , 2001, Advanced drug delivery reviews.

[24]  I. Goldstein,et al.  Nitric Oxide: A Review of Its Role in Retinal Function and Disease , 1996, Vision Research.

[25]  J. Robinson,et al.  Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[26]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[27]  M. Hediger,et al.  Distribution of peptide transporter PEPT2 mRNA in the rat nervous system , 1999, Anatomy and Embryology.

[28]  M. Tohyama,et al.  Cloning and expression of a bovine glutamate transporter. , 1995, Brain research. Molecular brain research.

[29]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[30]  The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy , 2004, Documenta Ophthalmologica.

[31]  L A Wheeler,et al.  Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. , 1999, Investigative ophthalmology & visual science.

[32]  V. Ganapathy,et al.  Expression of the extraneuronal monoamine transporter in RPE and neural retina , 2000, Current eye research.

[33]  H. Sarkar,et al.  Cloning, expression, and localization of a mouse retinal gamma-aminobutyric acid transporter. , 1994, Investigative ophthalmology & visual science.

[34]  L. Aiello,et al.  Hypoxic regulation of vascular endothelial growth factor in retinal cells. , 1995, Archives of ophthalmology.

[35]  T. Rauen.  Diversity of glutamate transporter expression and function in the mammalian retina , 2000, Amino Acids.

[36]  G. Fishman,et al.  EFFICACY OF DORZOLAMIDE HYDROCHLORIDE IN THE MANAGEMENT OF CHRONIC CYSTOID MACULAR EDEMA IN PATIENTS WITH RETINITIS PIGMENTOSA , 1997, Retina.

[37]  A. Mitra,et al.  Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration. , 2003, Experimental eye research.

[38]  J. Robinson,et al.  Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.

[39]  C. Grimm,et al.  Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium. , 2002, Investigative ophthalmology & visual science.

[40]  H. Takanaga,et al.  MCT1-Mediated Transport of L-Lactic Acid at the Inner Blood–Retinal Barrier: A Possible Route for Delivery of Monocarboxylic Acid Drugs to the Retina , 2001, Pharmaceutical Research.

[41]  Jean X. Jiang,et al.  Characterization of an N-system Amino Acid Transporter Expressed in Retina and Its Involvement in Glutamine Transport* , 2001, The Journal of Biological Chemistry.

[42]  R. Schoenwald.  Ocular pharmacokinetics/pharmacodynamics , 1993 .

[43]  R. Strieter,et al.  Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. , 1995, Current eye research.

[44]  K. Dutt,et al.  Nucleoside transport sites in a cultured human retinal cell line established by SV-40 T antigen gene. , 1994, Current eye research.

[45]  J. Cunha-Vaz,et al.  The blood-ocular barriers. , 1979, Survey of ophthalmology.

[46]  H. Lai,et al.  The saturation characteristics of glucose transport in bovine retinal pigment epithelium. , 1998, Yan ke xue bao = Eye science.

[47]  B. Ehinger,et al.  Expression of GABA transporter subtypes (GAT1, GAT3) in the adult rabbit retina. , 1999, Acta ophthalmologica Scandinavica.

[48]  J. Grunwald.  Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension. , 1990, Investigative ophthalmology & visual science.

[49]  U. Kompella,et al.  Possible existence of Na(+)-coupled amino acid transport in the pigmented rabbit conjunctiva. , 1995, Life sciences.

[50]  N. Mangini,et al.  P-glycoprotein expression in human retinal pigment epithelium. , 2002, Molecular vision.

[51]  K. Kenyon,et al.  Intraocular penetration of rifampin after oral administration , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[52]  S. Tarhan,et al.  Effects of Betaxolol and Latanoprost on Ocular Blood flow and Visual Fields in Patients with Primary Open-Angle Glaucoma , 2004, European journal of ophthalmology.

[53]  J. Baum,et al.  The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. , 1982, Investigative ophthalmology & visual science.

[54]  L. Drewes,et al.  Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina , 1999, Neuroscience.

[55]  P. Fasching,et al.  Nitric Oxide and Ocular Blood Flow in Patients With IDDM , 1997, Diabetes.

[56]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[57]  V. Sarthy,et al.  Nonsynaptic localization of the excitatory amino acid transporter 4 in photoreceptors , 2005, Molecular and Cellular Neuroscience.

[58]  D. Hu,et al.  Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[59]  W. Graninger,et al.  Penetration and decay of meropenem into the human aqueous humor and vitreous. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[60]  Taro Ogiso,et al.  Polar Solute Transport Across the Pigmented Rabbit Conjunctiva: Size Dependence and the Influence of 8-Bromo Cyclic Adenosine Monophosphate , 1997, Pharmaceutical Research.

[61]  D. Hatchell,et al.  N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina. , 1993, Experimental eye research.

[62]  H. Ueda,et al.  Functional characterization of organic cation drug transport in the pigmented rabbit conjunctiva. , 2000, Investigative ophthalmology & visual science.

[63]  J. Robinson,et al.  Mechanistic studies on transcorneal permeation of pilocarpine. , 1976, Journal of pharmaceutical sciences.

[64]  J. Holash,et al.  The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers , 1993, Brain Research.

[65]  H. Frenzel,et al.  Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy. , 1999, Survey of ophthalmology.

[66]  A. Milam,et al.  Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. , 1994, Ophthalmology.

[67]  G. A. Limb,et al.  Cytokines in proliferative vitreoretinopathy , 1991, Eye.

[68]  N. Philp,et al.  Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. , 2003, Investigative ophthalmology & visual science.

[69]  T. Abe,et al.  Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina. , 2002, Investigative ophthalmology & visual science.

[70]  M. Sebag,et al.  The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. , 1993, American journal of ophthalmology.

[71]  P. Gastaud,et al.  Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. , 1993, Ophthalmic research.

[72]  R. Keep,et al.  Preliminary Investigation into the Expression of Proton-Coupled Oligopeptide Transporters in Neural Retina and Retinal Pigment Epithelium (RPE): Lack of Functional Activity in RPE Plasma Membranes , 2003, Pharmaceutical Research.

[73]  F. Tyson,et al.  Vitreous concentration of topically applied brimonidine tartrate 0.2%. , 2001, Ophthalmology.

[74]  P. Rakoczy,et al.  Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy , 2002, Gene Therapy.

[75]  F. Vandenhende,et al.  LY333531 single escalating oral dose study in healthy volunteers. , 1998 .

[76]  I S Haworth,et al.  Proton-driven dipeptide uptake in primary cultured rabbit conjunctival epithelial cells. , 1998, Investigative ophthalmology & visual science.

[77]  J. Greenwood.  Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro , 1992, Journal of Neuroimmunology.

[78]  K. Kenyon,et al.  Comparative toxicity of intravitreal aminoglycoside antibiotics. , 1985, American journal of ophthalmology.

[79]  V. H. Lee,et al.  Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. , 1991, Current eye research.

[80]  D. Pow.  Amino acids and their transporters in the retina , 2001, Neurochemistry International.

[81]  J. Forrester,et al.  A model system for the study of human retinal angiogenesis: activation of monocytes and endothelial cells and the association with the expression of the monocarboxylate transporter type 1 (MCT-1) , 1999, Diabetologia.

[82]  R. Eagle,et al.  Retinal Pigment Epithelial Abnormalities in Fundus Flavimmaculatus , 1980 .

[83]  W. Thoreson,et al.  Expression of Multidrug Resistance-Associated Protein (MRP) in Human Retinal Pigment Epithelial Cells and Its Interaction with BAPSG, a Novel Aldose Reductase Inhibitor , 2001, Pharmaceutical Research.

[84]  R F Brubaker,et al.  Pharmacokinetics of fluorescein in the vitreous. , 1981, Investigative ophthalmology & visual science.

[85]  D. Maurice,et al.  Review: practical issues in intravitreal drug delivery. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[86]  C. Blazynski.  The accumulation of [3H]phenylisopropyl adenosine ([3H]PIA) and [3H]adenosine into rabbit retinal neurons is inhibited by nitrobenzylthioinosine (NBI) , 1991, Neuroscience Letters.

[87]  D. Charteris.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. , 1995, The British journal of ophthalmology.

[88]  Michael H. Miller,et al.  Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[89]  R. Lai,et al.  From the Lab to the Clinic: Activation of an Alpha-2 agonist Pathway is Neuroprotective in Models of Retinal and Optic Nerve Injury , 1999, European journal of ophthalmology.

[90]  Peter Wiedemann,et al.  Drug delivery systems for vitreoretinal diseases , 2004, Progress in Retinal and Eye Research.

[91]  S. Ueno,et al.  Effects of dorzolamide hydrochloride on ocular tissues. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[92]  R N Kalaria,et al.  Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[93]  L. Wheeler,et al.  Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[94]  P. Wiedemann,et al.  Diversity of aquaporin mRNA expressed by rat and human retinas , 2005, Neuroreport.

[95]  M. Boulton,et al.  Membrane-bound carbonic anhydrase in human retinal pigment epithelium. , 1994, Investigative ophthalmology & visual science.

[96]  M. Marmor,et al.  Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. , 1994, Ophthalmology.

[97]  P. Campochiaro,et al.  The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy. , 1995, Ophthalmology.

[98]  M. Willingham,et al.  Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[99]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[100]  V. Ganapathy,et al.  Taurine uptake in apical membrane vesicles from the bovine retinal pigment epithelium. , 1991, Investigative ophthalmology & visual science.

[101]  S. Majumdar,et al.  Mechanism of ganciclovir uptake by rabbit retina and human retinal pigmented epithelium cell line ARPE-19 , 2004, Current eye research.

[102]  J. Edelman,et al.  Active ion transport pathways in the bovine retinal pigment epithelium. , 1990, The Journal of physiology.

[103]  R. Cancedda,et al.  High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture. , 1991, Experimental cell research.

[104]  Xiong-Li Yang,et al.  Glutamate transporter EAAC1 is expressed on Müller cells of lower vertebrate retinas , 2001, Journal of neuroscience research.

[105]  E. Stool,et al.  Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. , 1988, Ophthalmology.

[106]  J. Sahel,et al.  The aging of the retina , 2003, Experimental Gerontology.

[107]  A. Alm,et al.  Lactate transport through the blood-retinal and the blood-brain barrier in rats. , 1985, Ophthalmic research.

[108]  Xiong-Li Yang,et al.  Expression of GABA transporters on bullfrog retinal Müller cells , 2000, Glia.

[109]  J. Forrester,et al.  Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. , 1994, Immunology.

[110]  A. Bozkurt,et al.  PENETRATION OF OFLOXACIN IN HUMAN AQUEOUS AND VITREOUS HUMORS FOLLOWING ORAL AND TOPICAL ADMINISTRATION , 1998, Retina.

[111]  M. Mandai,et al.  The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. , 1994, Investigative ophthalmology & visual science.

[112]  Clive G. Wilson,et al.  Topical drug delivery in the eye. , 2004, Experimental eye research.

[113]  Jennifer I. Lim,et al.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. , 1995, Investigative ophthalmology & visual science.

[114]  V. Lee,et al.  Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. , 1998, Investigative ophthalmology & visual science.

[115]  G. Hageman,et al.  Characterization of glucose transporter isoforms in the adult and developing human eye. , 1993, Endocrinology.

[116]  B. Schlosshauer,et al.  Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. , 2005, Investigative ophthalmology & visual science.

[117]  G. Grass,et al.  Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement. , 1988, Journal of pharmaceutical sciences.

[118]  K. Hosoya,et al.  Carrier-mediated transport of monocarboxylate drugs in the pigmented rabbit conjunctiva. , 1998, Investigative ophthalmology & visual science.

[119]  W. Stell,et al.  Identification and localization of an immunoreactiveAMPA-type glutamate receptor subunit (GluR4) with respect to identified photoreceptor synapses in the outer plexiform layer of goldfish retina , 1997, Journal of neurocytology.

[120]  Jayakrishna Ambati,et al.  Transscleral drug delivery to the retina and choroid , 2002, Progress in Retinal and Eye Research.

[121]  A. Alm,et al.  Carrier-mediated transport of amino acids through the blood-retinal and the blood-brain barriers , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[122]  J. L. van Delft,et al.  Nitric oxide plays a role as a mediator of conjunctival edema in experimental allergic conjunctivitis. , 1996, Experimental eye research.

[123]  J. Pulido,et al.  Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression. , 1988, The British journal of ophthalmology.

[124]  M. Araie,et al.  Topical latanoprost and optic nerve head and retinal circulation in humans. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[125]  B. Kuppermann,et al.  Perfluorooctane in the Treatment of Giant Retinal Tears with Proliferative Vitreoretinopathy , 1991 .

[126]  B. Chauhan,et al.  Timolol Concentrations in Rat Ocular Tissues and Plasma After Topical and Intraperitoneal Dosing , 2002, Journal of glaucoma.

[127]  K. Hosoya,et al.  Na(+)-dependent L-arginine transport in the pigmented rabbit conjunctiva. , 1997, Experimental eye research.

[128]  T. Miyata,et al.  Soluble gentamicin ophthalmic inserts as a drug delivery system. , 1978, Archives of ophthalmology.

[129]  S. Miller,et al.  Identification and functional characterization of a dual GABA/taurine transporter in the bullfrog retinal pigment epithelium , 1995, The Journal of general physiology.

[130]  E. Vingolo,et al.  Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study , 2004, International Ophthalmology.

[131]  A. Mitra,et al.  Ophthalmic Drug Delivery Systems , 2003 .

[132]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[133]  B. S. Winkler.  Glycolytic and oxidative metabolism in relation to retinal function , 1981, The Journal of general physiology.

[134]  M. Gottlieb,et al.  Treatment of cytomegalovirus retinopathy with ganciclovir. , 1987, Ophthalmology.

[135]  Ronald Klein,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[136]  V. Ganapathy,et al.  Properties of taurine transport in a human retinal pigment epithelial cell line. , 1993, Current eye research.

[137]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. , 1984, Ophthalmology.

[138]  P. Sieving,et al.  Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Kwang-Jin Kim,et al.  Role of P-Glycoprotein in Restricting Propranolol Transport in Cultured Rabbit Conjunctival Epithelial Cell Layers , 2000, Pharmaceutical Research.

[140]  D. Wurster,et al.  Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-delta2-1,3,4,-thiadiazolin e-2-sulfonamide. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[141]  J. Forrester,et al.  Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA in bovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture , 1993, Diabetologia.

[142]  K. Hosoya,et al.  Kinetic evidence for Na(+)-glucose co-transport in the pigmented rabbit conjunctiva. , 1997, Current eye research.

[143]  N. Saito,et al.  Immunocytochemical localization of three subtypes of GABA transporter in rat retina. , 1995, Brain research. Molecular brain research.

[144]  F. M. Wilson.  CAUSES AND PREVENTION OF ENDOPHTHALMITIS , 1987, International ophthalmology clinics.

[145]  M. Weller,et al.  Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. , 1998, Investigative ophthalmology & visual science.

[146]  O. Candia,et al.  Active sodium and chloride transport across the isolated rabbit conjunctiva. , 1995, Current eye research.

[147]  U. Kompella,et al.  Contribution of Na(+)-glucose cotransport to the short-circuit current in the pigmented rabbit conjunctiva. , 1996, Current eye research.

[148]  S. Hamann,et al.  Cotransport of H+, lactate, and H2O in porcine retinal pigment epithelial cells. , 2003, Experimental eye research.

[149]  E S Gragoudas,et al.  Diffusion of high molecular weight compounds through sclera. , 2000, Investigative ophthalmology & visual science.

[150]  E. Nagelhus,et al.  Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat , 1999, Neuroscience.

[151]  T. F. Patton,et al.  Importance of the noncorneal absorption route in topical ophthalmic drug delivery. , 1985, Investigative ophthalmology & visual science.

[152]  A. Mitra,et al.  Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS , 2002, Current eye research.